• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

被忽视热带病疫苗的产品开发模式:一种抗人钩虫疫苗

Model for product development of vaccines against neglected tropical diseases: a vaccine against human hookworm.

作者信息

Bottazzi Maria Elena, Brown Ami Shah

机构信息

Department of Microbiology, Immunology and Tropical Medicine, The George Washington University, 2300 Eye Street NW, Ross Hall, Washington, DC 20037, USA.

出版信息

Expert Rev Vaccines. 2008 Dec;7(10):1481-92. doi: 10.1586/14760584.7.10.1481.

DOI:10.1586/14760584.7.10.1481
PMID:19053205
Abstract

This article provides an overview of the advances in product development and technology transfer of the vaccine against human hookworm, with particular emphasis on the lessons learned and the challenges of developing a vaccine in the nonprofit sector. The comprehensive approach to vaccine development established by the Human Hookworm Vaccine Initiative (HHVI) identifies key operational and technical aspects that are essential for a successful partnership with a developing country vaccine manufacturer. This article also highlights the importance of a global access roadmap to guide the vaccine development program. The advancement of new products for the control of neglected tropical diseases portends great challenges for global access, including aspects related to vaccine design, product development and manufacture, vaccine introduction and distribution, financing, knowledge dissemination and intellectual property management. With only three vaccines for neglected tropical diseases in clinical trials - hookworm, leishmaniasis and schistosomiasis - we are at the nascent stages of developing vaccines for neglected populations. Product development public-private partnerships, such as the HHVI, continue to show great promise on this front and will eventually provide significant control tools for achieving millennium development goals related to poverty reduction, as well as child and maternal health.

摘要

本文概述了抗人钩虫疫苗在产品开发和技术转让方面的进展,特别强调了所吸取的经验教训以及在非营利部门开发疫苗所面临的挑战。人类钩虫疫苗倡议组织(HHVI)确立的全面疫苗开发方法确定了与发展中国家疫苗制造商成功合作所必需的关键运营和技术方面。本文还强调了全球准入路线图对指导疫苗开发计划的重要性。用于控制被忽视热带病的新产品的研发给全球准入带来了巨大挑战,包括与疫苗设计、产品开发与生产、疫苗引入与分发、融资、知识传播和知识产权管理等相关的方面。目前仅有三种用于被忽视热带病的疫苗处于临床试验阶段——钩虫疫苗、利什曼病疫苗和血吸虫病疫苗——我们在为被忽视人群研发疫苗方面仍处于初期阶段。诸如HHVI这样的公私合营产品开发伙伴关系在这方面继续展现出巨大潜力,并最终将为实现与减贫以及儿童和孕产妇健康相关的千年发展目标提供重要的控制手段。

相似文献

1
Model for product development of vaccines against neglected tropical diseases: a vaccine against human hookworm.被忽视热带病疫苗的产品开发模式:一种抗人钩虫疫苗
Expert Rev Vaccines. 2008 Dec;7(10):1481-92. doi: 10.1586/14760584.7.10.1481.
2
An ounce of prevention on a budget: a nonprofit approach to developing vaccines against neglected diseases.低成本的一盎司预防措施:一种开发针对被忽视疾病疫苗的非营利性方法。
Expert Rev Vaccines. 2006 Apr;5(2):189-98. doi: 10.1586/14760584.5.2.189.
3
Neglected tropical disease vaccines.被忽视的热带病疫苗。
Biologicals. 2009 Jun;37(3):160-4. doi: 10.1016/j.biologicals.2009.02.008. Epub 2009 Mar 17.
4
New technologies for the control of human hookworm infection.控制人体钩虫感染的新技术。
Trends Parasitol. 2006 Jul;22(7):327-31. doi: 10.1016/j.pt.2006.05.004. Epub 2006 May 18.
5
Multivalent anthelminthic vaccine to prevent hookworm and schistosomiasis.用于预防钩虫病和血吸虫病的多价抗蠕虫疫苗。
Expert Rev Vaccines. 2008 Aug;7(6):745-52. doi: 10.1586/14760584.7.6.745.
6
The human hookworm vaccine: recent updates and prospects for success.人钩虫疫苗:近期进展与成功前景
J Helminthol. 2015 Sep;89(5):540-4. doi: 10.1017/S0022149X15000206. Epub 2015 Apr 8.
7
Hookworm and poverty.钩虫与贫困。
Ann N Y Acad Sci. 2008;1136:38-44. doi: 10.1196/annals.1425.000. Epub 2007 Oct 22.
8
The antipoverty vaccines.抗贫困疫苗。
Vaccine. 2006 Jul 26;24(31-32):5787-99. doi: 10.1016/j.vaccine.2006.05.008. Epub 2006 May 17.
9
The Human Hookworm Vaccine.人钩虫疫苗。
Vaccine. 2013 Apr 18;31 Suppl 2(Suppl 2):B227-32. doi: 10.1016/j.vaccine.2012.11.034.
10
Potency testing for the experimental Na-GST-1 hookworm vaccine.实验性 Na-GST-1 钩虫疫苗的效力检测。
Expert Rev Vaccines. 2010 Oct;9(10):1219-30. doi: 10.1586/erv.10.107.

引用本文的文献

1
Reforming the innovation system to deliver affordable medicines: a conceptual framework of pharmaceutical innovation as a complex adaptive system (forest) and theory of change.改革创新体系以提供可负担药品:作为复杂适应系统(森林)的药物创新概念框架及变革理论。
J Pharm Policy Pract. 2025 Jan 16;18(1):2436899. doi: 10.1080/20523211.2024.2436899. eCollection 2025.
2
Insights for the future of health system partnerships in low- and middle-income countries: a systematic literature review.低、中收入国家卫生系统伙伴关系的未来展望:系统文献回顾。
BMC Health Serv Res. 2020 Jun 22;20(1):571. doi: 10.1186/s12913-020-05435-8.
3
The human hookworm vaccine: recent updates and prospects for success.
人钩虫疫苗:近期进展与成功前景
J Helminthol. 2015 Sep;89(5):540-4. doi: 10.1017/S0022149X15000206. Epub 2015 Apr 8.
4
Developing vaccines to combat hookworm infection and intestinal schistosomiasis.研发疫苗以对抗钩虫感染和肠道血吸虫病。
Nat Rev Microbiol. 2010 Nov;8(11):814-26. doi: 10.1038/nrmicro2438.